- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
ALTEOGEN
Market Cap: ₩22.5t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩405,500.00
7D
-7.2%
1Y
40.3%
Celltrion
Market Cap: ₩37.9t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩171,700.00
7D
-1.9%
1Y
-7.4%